Genomictree Inc. (KOSDAQ:228760)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,180
-110 (-0.97%)
Sep 1, 2026, 3:30 PM KST

Genomictree Revenue

Genomictree had revenue of 842.32M KRW in the quarter ending June 30, 2026, a decrease of -51.06%. This brings the company's revenue in the last twelve months to 2.95B, down -17.13% year-over-year. In the year 2025, Genomictree had annual revenue of 3.76B with 59.17% growth.

Revenue (ttm)
2.95B
Revenue Growth
-17.13%
P/S Ratio
93.98
Revenue / Employee
n/a
Employees
n/a
Market Cap
276.90B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.76B1.40B59.17%
Dec 31, 20242.36B-1.06B-30.89%
Dec 31, 20233.42B-26.45B-88.56%
Dec 31, 202229.87B24.73B481.09%
Dec 31, 20215.14B3.90B314.87%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
GC Corp.2.49T
Bioneer338.01B
Medy-Tox251.08B
GC Cell162.00B
MEDIPOST74.84B
HLB Therapeutics64.45B
SillaJen10.92B
GI Innovation5.63B
Revenue Rankings